# EDGAR Filing Document

**Accession Number:** 0001867090
**File Stem:** 0001999371-25-008874
**Filing Date:** 2025-7
**Character Count:** 8286
**Document Hash:** 3b1b387eaa7389d19efe9eac197c5476
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001999371-25-008874.hdr.sgml**: 20250709

**ACCESSION NUMBER**: 0001999371-25-008874

**CONFORMED SUBMISSION TYPE**: SC TO-I/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250709

**DATE AS OF CHANGE**: 20250709

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Fundrise Growth Tech Fund, LLC
- **CENTRAL INDEX KEY:** 0001867090

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93831
- **FILM NUMBER:** 251113522

**BUSINESS ADDRESS:**
- **STREET 1:** 11 DUPONT CIRCLE NW
- **STREET 2:** 9TH FLOOR
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036
- **BUSINESS PHONE:** 202-584-0550

**MAIL ADDRESS:**
- **STREET 1:** 11 DUPONT CIRCLE NW
- **STREET 2:** 9TH FLOOR
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Fundrise Growth Tech Interval Fund, LLC
- **DATE OF NAME CHANGE:** 20210611
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Fundrise Growth Tech Fund, LLC
- **CENTRAL INDEX KEY:** 0001867090

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I/A

**BUSINESS ADDRESS:**
- **STREET 1:** 11 DUPONT CIRCLE NW
- **STREET 2:** 9TH FLOOR
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036
- **BUSINESS PHONE:** 202-584-0550

**MAIL ADDRESS:**
- **STREET 1:** 11 DUPONT CIRCLE NW
- **STREET 2:** 9TH FLOOR
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Fundrise Growth Tech Interval Fund, LLC
- **DATE OF NAME CHANGE:** 20210611

**UNITED STATES <br> SECURITIES AND EXCHANGE COMMISSION<br> WASHINGTON, D.C. 20549**

**SCHEDULE TO**

**TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1)<br> OF THE SECURITIES EXCHANGE ACT OF 1934<br> (Amendment No. 1)**

**Fundrise Growth Tech Fund, LLC**<br> (Name of Issuer)

**Fundrise Growth Tech Fund, LLC**<br> (Name of Person(s) Filing Statement)

**COMMON SHARES OF BENEFICIAL INTEREST**<br> (Title of Class of Securities)

**N/A**<br> (CUSIP Number of Class of Securities)

**Lauren Stuntebeck<br> Rise Companies Corp.<br> 11 Dupont Circle NW, 9<sup>th</sup> Floor<br> Washington, D.C. 20036<br> (202) 584-0550**

(Name, Address, and Telephone Number of Person Authorized to Receive Notices and<br> Communications on Behalf of the Person(s) Filing Statement)

*With a copy to:*

**Elizabeth J. Reza<br> Ropes & Gray LLP<br> 800 Boylston Street<br> Boston, Massachusetts 02199**

☐ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

☐ third-party tender offer subject to Rule 14d-1.

☒ issuer tender offer subject to Rule
13e-4.

☐ going-private transaction subject to Rule 13e-3.

☐ amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results of the tender offer: ☒

INTRODUCTORY STATEMENT

This is the final amendment to the Issuer Tender Offer Statement ("Statement") on Schedule TO filed with the Securities and Exchange Commission on May 29, 2025 (the "Statement Filing Date") by Fundrise Growth Tech Fund, LLC (the "Fund") relating to an offer to purchase the Fund's common shares of beneficial interest ("Common Shares") in an amount up to 5% of the Fund from shareholders of the Fund ("Shareholders") at their net asset value (i.e., the value of the assets of the Fund's Common Shares minus its liabilities, divided by the number of Common Shares outstanding) on the terms, and subject to the conditions, set out in the Offer to Repurchase ("Offer") and the related Letter of Transmittal. Copies of the Offer and Letter of Transmittal were previously filed as exhibits to the Statement on the Statement Filing Date.

This final amendment to the Statement is being filed to report the results of the Offer. The following information is furnished pursuant to Rule 13e-4(c)(4) of the Securities Exchange Act of 1934:

1. Shareholders which desired to tender Common Shares were required to submit their tenders by 11:59 p.m., Eastern Time, on June 30, 2025 (the "Expiration Date"). Shareholders were allowed to withdraw any tenders of their Common Shares until the Expiration Date.

2. Certain Shareholders validly tendered all or some of their respective Common Shares (as designated by such Shareholders) before the Expiration Date and did not withdraw such tenders before the Expiration Date. Those tenders were accepted for repurchase by the Fund in accordance with the terms of the Offer.

3. The net asset value of the Common Shares tendered pursuant to the Offer was calculated as of July 1, 2025 (the "Valuation Date") in the amount of $12.56.

4. The payment of the purchase price of the Common Shares tendered was made to the Shareholders whose tenders were accepted for purchase by the Fund in accordance with the terms of the Offer. On or about July 7, 2025, the Fund paid to the tendering Shareholders a total of $3,510,094.22, representing 100% of the unaudited net asset value of the total amount of the Common Shares tendered by Shareholders.

Except as specifically provided herein, the information contained in the Statement, Offer, and the related Letter of Transmittal previously filed on May 29, 2025 (the "Tender Offer Materials") remains unchanged and this final amendment does not modify any of the information previously reported in the Tender Offer Materials.

**Item 1 through Item 9 and Item 11.**

The information set forth in the Tender Offer Materials is incorporated herein by reference into this final amendment in answer to Item 1 through Item 9 and Item 11 of Schedule TO.

**Item 12(a). Exhibits**

Not applicable.

**Item 12(b). Filing Fee**

Calculation of Filing Fee Tables is [attached herewith](ex107.htm).

**Item 13. Information Required by Schedule 13E-3**

Not applicable.

**SIGNATURE**

After due inquiry and to the best of my knowledge and belief, I certify that the information set out in this statement is true, complete, and correct.

---

| | |
|:---|:---|
| **FUNDRISE GROWTH TECH FUND, LLC** | **FUNDRISE GROWTH TECH FUND, LLC** |
| By: | /s/ Lauren Stuntebeck |
| Name: | Lauren Stuntebeck |
| Title: | Assistant Treasurer |

---

July 9, 2025

## Ex-Filing

[Fundrise Growth Tech Fund, LLC SC TO-I/A](fundrise-sctoia_070925.htm)

**Exhibit 107**

**CALCULATION OF FILING FEE TABLE**

<u>Table 1 – Transaction Valuation</u>

---

| | | | |
|:---|:---|:---|:---|
| | **Transaction Valuation** | **Fee Rate** | **Amount of Filing Fee** |
| &nbsp;&nbsp;Fees to be Paid |  | 0.015310% |  |
| &nbsp;&nbsp;Fees Previously Paid | $12063544.66 <sup>(a)</sup> |  | $1846.93 <sup>(a)</sup> |
| &nbsp;&nbsp;**Total Transaction Valuation** | $3510094.22 <sup>(b)</sup> |  |  |
| &nbsp;&nbsp;**Total Fees Due for Filing** |  |  | $537.40 <sup>(b)(c)</sup> |
| &nbsp;&nbsp;**Total Fees Previously Paid** |  |  | $1846.93 <sup>(c)</sup> |
| &nbsp;&nbsp;**Total Fee Offsets** |  |  |  |
| &nbsp;&nbsp;**Net Fee Due** |  |  | $0 |

---

<sup></sup> 

<sup>(a)</sup> The transaction value is calculated as the aggregate maximum value of Shares being purchased. A fee of $1,846.93 was paid in connection with the filing of the Schedule TO-I by Fundrise Growth Tech Fund, LLC (the "Fund") (File No. <u>005-93831</u>) on May 29, 2025 (the "Schedule TO"), which filing fee amount was based on the aggregate maximum purchase price for common shares of beneficial interest being offered to be purchased pursuant to the tender offer, based upon the estimated net asset value per common share as of May 28, 2025. This is the final amendment to the Schedule TO and is being filed to report the results of the offer.

<sup>(b)</sup> Calculated as the aggregate maximum purchase price for common shares of beneficial interest tendered (279,466.10) based upon the net asset value per common share as of July 1, 2025 ($12.56).

<sup>(c)</sup> Calculated as $153.10 per $1,000,000 of the Transaction Valuation.